Aging- and smoking-associated alteration in the relative content of mitochondrial DNA in human lung  by Lee, Hsin-Chen et al.
Aging- and smoking-associated alteration in the relative content of
mitochondrial DNA in human lung
Hsin-Chen Lee, Ching-You Lu, Huei-Jyh Fahn, Yau-Huei Wei*
Department of Biochemistry and Center for Cellular and Molecular Biology, National Yang-Ming University, Taipei 112, Taiwan
Received 16 November 1998
Abstract mtDNA mutations and oxidative DNA damage has
been observed to accumulate in the lung and other tissues in
human aging. Thus, it is of interest to know whether the content
of mtDNA is changed in aging tissues of the human. Using a
competitive PCR method, we determined the relative content of
mtDNA in the lung tissues of 49 subjects aged 16^85 years. The
results showed that the relative content of mtDNA (with respect
to the L-actin gene) in the lung tissues was significantly increased
with age (P6 0.005). The average mtDNA content in the lung
tissues of the subjects over 80 years of age was found to be about
2.6-fold higher than that of the subjects below age 20. However,
the relative content of mtDNA was slightly increased in the lung
tissues of light smokers but significantly decreased in heavy
smokers. Moreover, we found a significant increase with age in
the level of oxidative damage to DNA as indicated by the ratio of
8-OH-dG/dG in total DNA (P6 0.0005). These results together
with our previous findings suggest that the increase in mtDNA
content of aging tissues may be effected through a feedback
mechanism to compensate for the functional decline of mitochon-
dria in human aging and that smoking may modulate the
mechanism.
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1. Introduction
Mitochondrial respiratory function has been demonstrated
to decline in various human tissues during the aging process
[1^3]. This is thought to be caused, at least partly, by oxida-
tive damage and mutation of mitochondrial DNA (mtDNA)
in somatic tissues of aged individuals [3].
The mitochondrial mass and mtDNA copy number of in-
dividual cells vary with the type of cell and tissue, and are
changed during cell di¡erentiation, hormone treatment and
exercise [4^6]. In addition, gene expressions of both nuclear
and mitochondrial genomes have been demonstrated to re-
spond in a complex manner to a variety of physiological
and developmental signals [7]. Over-proliferation of mito-
chondria and an increased synthesis of mitochondrial respira-
tory enzymes are often observed in patients with mitochon-
drial myopathies [8]. However, it remains unclear how the
tissue cells respond to the decline of mitochondrial function
in human tissue during the aging process.
Cigarette smoke contains more than 3800 compounds, in-
cluding potent carcinogens, such as benzo[a]pyrene, and a
substantial amount of free radical forming substances, such
as hydroquinone. These organic radicals and toxic agents may
cause extensive damage to DNA, proteins and lipids [9].
Moreover, human mtDNA is extremely compact and has no
protective histones, and is replicated without e⁄cient proof-
reading and DNA repair systems [10]. These unique character-
istics render mtDNA susceptible to damage by reactive oxy-
gen species (ROS) and genotoxic agents [11]. Accumulation of
these toxic products in human lung may lead to an increase of
DNA damage and impairment of mitochondrial respiratory
function. In previous studies, we have shown that mtDNA
mutations, oxidative DNA damage and lipid peroxidation
are increased during aging in the human lung [12,13] and
other tissues [14,15]. In addition, smokers were found to
have more extensive damage to DNA and lipids in the lung
tissues as compared with non-smokers [16]. However, the ef-
fect of smoking on the mtDNA content in the lung in re-
sponse to oxidative DNA damage and mtDNA mutation is
unclear.
In this study, we established a competitive PCR method for
the quanti¢cation of mtDNA with respect to the L-actin gene
of nuclear DNA in the lung tissues. The signi¢cance of the
alteration of the relative content of mtDNA in the lung tissue
during aging and smoking is discussed.
2. Materials and methods
2.1. Human lung tissues
The lung tissues examined in this study were obtained from 49
patients at the Division of Thoracic Surgery, Veterans General Hos-
pital-Taipei, who underwent surgical resection for treatment of vari-
ous pulmonary diseases, including spontaneous pneumothorax, meta-
static lung tumors and bronchogenic carcinoma. None of the patients
recruited in the study had a known history of industrial or occupa-
tional exposure to asbestos or organic solvent. A small piece of the
lung tissue (ca. 350 mg) was collected from the grossly normal region
of the resected specimen and quickly frozen in liquid nitrogen until
analysis. The study subjects were 25 non-smokers and 24 smokers,
who were between 16 and 85 years of age. The smoking index is
expressed as pack-years (cigarettes or parts thereof smoked per
dayUyears of smoking/20).
2.2. Competitive polymerase chain reaction
A competitive PCR method similar to that developed by Gilliland
et al. [17] was used for the quanti¢cation of DNA. The competitor
DNA was constructed by a method similar to that described by Celi et
al. [18]. The nucleotide sequences of the primers used in this study are
described in Table 1. To generate an internal DNA standard (Fig. 1),
a plasmid was constructed by cloning the PCR product in the pGEM-
T vector (Promega Co., Madison, WI). A known amount of the in-
ternal DNA standard was introduced with the lung DNA sample into
the PCR reaction mixture. Each aliquot of 50 Wl reaction mixture
contained 200 WM of each dNTP, 5 WCi of [K-33P]dATP, 20 pmol
of each primer, 1 unit of Taq DNA polymerase (Perkin-Elmer/Cetus,
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Norwalk, CT), 50 mM KCl, 1.5 mM MgCl2 and 10 mM Tris-HCl
(pH 8.3). PCR was carried out with 30 s denaturation at 94‡C, 20 s
annealing at 58‡C and 40 s extension at 72‡C for 30 cycles in a Perkin-
Elmer/Cetus DNA thermal cycler. The PCR products were separated
electrophoretically in a 3% agarose gel. A Kodak X-ray ¢lm was
exposed for 4^6 h to the gel after it had been vacuum dried. The
intensities of the PCR products of the target and competitor DNAs
were analyzed by scanning densitometry for each reaction. In each
competitive PCR run, a standard curve was constructed by plotting
the competitor/target DNA intensity ratio against the logarithm of the
content of the internal DNA standard added to the reaction mixture
(Fig. 2). Using this method, the relative content of mtDNA was cal-
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Fig. 1. The construction of the competitor DNA for competitive PCR. A: A 319 bp and a 289 bp PCR product were ampli¢ed from human
L-actin gene with primers BA1 and BA2 (lane 1) and with primers BA1 and BA2^BA3 (lane 2), respectively. A plasmid was constructed by in-
sertion to the pGEM-T vector of the PCR product ampli¢ed with primers BA1 and BA2^BA3. A 289 bp PCR product was ampli¢ed from the
plasmid with primers BA1 and BA2 (lane 3). When a known amount of the internal DNA standard was introduced into the sample and ampli-
¢ed with primers BA1 and BA2, two products with sizes of 319 bp and 289 bp were generated, respectively, from the endogenous template and
from the internal DNA standard (lane 4). Lane M is the 100 bp DNA marker. B: With the same approach, a 347 bp and a 316 bp PCR prod-
uct were ampli¢ed from the ND1 gene of human mtDNA with primers L3540 and H3887 (lane 1) and with primers L3540 and H3887-h3836
(lane 2), respectively. A plasmid was constructed by insertion to the pGEM-T vector of the PCR product that was ampli¢ed with primers
L3540 and H3887-h3836. A 316 bp PCR product was ampli¢ed from the plasmid with primers L3540 and H3887 (lane 3). When a known
amount of the internal DNA standard was introduced into the DNA sample and ampli¢ed with primers L3540 and H3887, two products with
sizes of 347 bp and 316 bp were generated, respectively, from the endogenous template and from the internal DNA standard (lane 4).
Fig. 2. Competitive PCR. A: The amount of unknown wild-type target DNA was determined by comparison of the amount of the wild-type
PCR product with the amount of the PCR product derived from an internal DNA standard. The band intensities of the wild-type and compet-
itor PCR products were analyzed by scanning densitometry for each reaction. B and C: Standard curves constructed by plotting the ratio of
competitor/target DNA intensity against the logarithm of the amount of the internal DNA standard added to the reaction to quantify the
amount of nuclear DNA (L-actin gene) and mtDNA (ND1 gene), respectively. The best-¢t line was established and the corresponding algebraic
equation was used to calculate the relative amount of target DNA.
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culated as an equivalent of one copy of L-actin gene and normalized
with a factor of 25 for the di¡erence in ampli¢cation e⁄ciency be-
tween the two pairs of primers for L-actin and ND1 genes, respec-
tively.
2.3. Analysis of the 8-hydroxy-2P-deoxyguanosine (8-OH-dG) content
in lung DNA
The 8-OH-dG content of each lung DNA sample was determined
according to the procedure described by Lu et al. [15]. The 8-OH-dG
and dG contents in the total DNA of lung tissues were determined by
an HPLC-ECD/UV detector system after sequential enzyme diges-
tions at 37‡C of freshly isolated DNA with DNase I, nuclease P1
and alkaline phosphatase, respectively. Deoxyguanosine (dG) (Sigma
Chemical Co., St. Louis, MO) and 8-OH-dG (Cayman Chemical Co.,
Ann Arbor, MI) were used as standards.
3. Results
By use of the competitive PCR method, we determined the
relative content of mtDNA in the lung tissues of 49 subjects
who were 16^85 years of age. The results showed that the
relative content of mtDNA (with respect to the L-actin
gene) in the lung tissues was signi¢cantly increased with age
(P6 0.005) (Fig. 3). The average relative content of mtDNA
(179.5 þ 22.8, mean þ S.E.M., n = 5) of subjects in the group
over 80 years of age was found to be about 2.6-fold higher
than that (67.5 þ 5.3, mean þ S.E.M., n = 3) of subjects in the
group younger than 20 years of age.
In the group of subjects over 60 years of age, the average
relative contents of mtDNA in the lung tissues of non-smok-
ers (n = 10), light smokers (smoking index 6 30 pack-years,
n = 8) and heavy smokers (smoking index v 30 pack-
years, n = 12) were 150.1 þ 16.4, 181.9 þ 26.1 and 114.4 þ 14.9
(mean þ S.E.M.), respectively. The average relative content of
mtDNA in the lung tissues of light smokers was slightly high-
er than that of the non-smokers (P = 0.15, Student’s t-test).
However, the average content of mtDNA in the lung tissues
of heavy smokers was signi¢cantly lower than that of light
smokers (P6 0.05, Student’s t-test, Fig. 4).
In order to assess the oxidative damage to DNA, we deter-
mined the relative content of 8-OH-dG in total DNA of lung
tissues from subjects of di¡erent ages. The results showed a
signi¢cant increase with age in the tissue level of the 8-OH-
dG/dG ratio (P6 0.0005, Fig. 5).
4. Discussion
The lung tissue is continually subjected to ROS and free
radicals generated by electron leak from the respiratory chain
as well as exogenous sources such as cigarette smoke and air
pollutants. The lung may serve as a good system to study the
impact of environmental factors on human tissues during
aging. Exogenous sources of ROS and free radicals, such as
those derived from cigarette smoke, may aggravate the oxida-
tive damage and mutation of mtDNA in aging human tissues.
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Fig. 3. Increase of the relative content of mtDNA in human lung.
The relative content of mtDNA of each of the 49 lung samples was
determined by the competitive PCR method illustrated in Fig. 2.
The relative content of mtDNA (with respect to the L-actin gene) in
the lung tissues was found to signi¢cantly increase with age
(P6 0.005).
Fig. 4. The e¡ect of smoking on the relative content of mtDNA in
the lung tissues of aged individuals. In the group of subjects over
60 years of age, the average relative contents of mtDNA in the lung
tissues of non-smokers (n = 10), light smokers (smoking index 6 30
pack-years, n = 8) and heavy smokers (smoking index v 30 pack-
years, n = 12) were found to be 150.1 þ 16.4, 181.9 þ 26.1 and
114.4 þ 14.9 (mean þ S.E.M.), respectively. The average content of
mtDNA in the lung tissues of heavy smokers was lower than that
of light smokers (P6 0.05, Student’s t-test). The average mtDNA
content in the lung of light smokers was higher than that of non-
smokers, but the di¡erence did not reach statistical signi¢cance
(P = 0.15, Student’s t-test).
Table 1
Sequences of the primers used in this study
Primer Sequence (5P to 3P) Target DNA
BA1 CATGTGCAAGGCCGGCTTCG nDNA, L-actin
BA2 CTGGGTCATCTTCTCGCGGT nDNA, L-actin
BA2^BA3 CTGGGTCATCTTCTCGCGGTGCAGCACGGGGTGCTCCTC nDNA, L-actin
L3540 TCTCACCATCGCTCTTCTAC mtDNA, ND1
H3887 TTGGTCTCTGCTAGTGTGGA mtDNA, ND1
H3887-h3836 TTGGTCTCTGCTAGTGTGGAGGCAGGAGTAATCAGAGGT mtDNA, ND1
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In the past decade, a number of mtDNA mutations have been
found to accumulate in various tissues of aged individuals [3].
Oxidative damage and mutation of mtDNA may be facilitated
by cigarette smoke and synergistically cause the age-depend-
ent decline of the respiratory function of mitochondria [3,13].
These earlier observations have prompted us to investigate
whether the mtDNA content is altered in the lung tissues as
a function of age or smoking index.
In this study, we demonstrated for the ¢rst time that the
relative content of mtDNA in human lung is increased with
age. This is consistent with the previous observation that the
mtDNA copy numbers in liver, heart and brain of senescent
rats are higher than those of the adult counterparts [19].
Moreover, it was reported recently that the content of
mtDNA in the HeLa S3 cells is increased about 2-fold after
treatment with 0.1 WM rotenone, which inhibits complex I
activity [20]. These results support the idea that as respiratory
function declines with age, the tissue cells are able to manage
to compensate for the reduced ATP synthesis by inducing the
proliferation of mitochondria and/or increasing expression of
the OXPHOS genes.
The rate of production of superoxide anions and hydrogen
peroxide in mitochondria was shown to increase with age in
animal tissues [21]. Since the mitochondrial genome is more
susceptible to free radical attack [3,11,22], it would be of
interest to determine if the oxidative damage to mtDNA in
human lung is more extensive than that to nuclear DNA
during aging and upon smoking. However, due to the limited
amount of lung tissues available from each of the study sub-
jects, we could only determine the content of 8-OH-dG in the
total DNA of human lung tissues. The results showed that
oxidative DNA damage, indicated by the 8-OH-dG/dG ratio,
in the lung is increased with age (P6 0.0005, Fig. 5). ROS and
free radicals have been established to be able to act as second-
ary messengers to activate the transcription factors including
NF-UB and AP-1 [23]. We conjectured that oxidative stress
and oxidative DNA damage may elicit activation of replica-
tion and/or transcription of mtDNA in lung tissues. Recently,
it was observed that human cells could respond to the impair-
ment of electron transfer by promoting the expression of both
nuclear and mitochondrial genes, through an H2O2-dependent
signaling pathway [24]. Therefore, the increased production of
superoxide anions and hydrogen peroxide from mitochondria
in aging human tissues may be one of the factors involved in
the feedback mechanisms of the compensation for the age-
dependent increase of the oxidative damage and functional
deterioration of mitochondria. This will allow tissue cells to
adapt to the decline of mitochondrial respiratory function
during the aging process.
On the other hand, it has been demonstrated that increased
DNA adducts and/or single-strand breaks of mtDNA can not
only increase mtDNA damage but also inhibit mtDNA repli-
cation in the lung tissues of smokers [25]. This is consistent
with our ¢nding that the relative content of mtDNA was
decreased in the lungs of heavy smokers (Fig. 4). These results
suggest that cigarette smoking could modulate, in a negative
manner, the mtDNA content in the lung tissues of the smok-
ers.
In summary, this study clearly demonstrated that oxidative
DNA damage and the relative content of mtDNA in human
lung tissues are increased concurrently during aging. More-
over, long-term heavy cigarette smoking causes a signi¢cant
decrease in the mtDNA content in the lung tissues of aged
individuals. We thus suggest that the increase in mtDNA con-
tent may be e¡ected through a feedback mechanism to com-
pensate for the respiratory function decline of the mitochon-
dria harboring mtDNA with oxidative damage or mutation in
aging lung tissues, and that cigarette smoking may modulate
this mechanism in a negative manner.
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